LexDanaLexDanabeta
Inventor

Charles M. CONWAY

Inventor
US

Overview

2→
Patents
2024–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
PatentTitleYear
12,564,579Topical formulations of (1S)-1-phenyl-2-pyridin-2-ylethanamine202612,030,868Prodrugs of CGRP antagonists2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024Patents assigned to PFIZER IRELAND PHARMACEUTICALS (1)· patent assignee history
2024–2026Based in US· patent location history
2026Patents assigned to BIOHAVEN THERAPEUTICS LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOHAVEN THERAPEUTICS LTD12026
PFIZER IRELAND PHARMACEUTICALS12024
Locations
LocationPatentsSpan
US22024–2026